Morris & Dickson Acquires Prodigy Health

January 26, 2026

Morris & Dickson has completed the acquisition of Prodigy Health (now operating as ProdigyMD), a specialty pharmaceutical distributor focused on plasma-derived therapies. The acquisition expands Morris & Dickson's specialty distribution capabilities and access to hospitals, specialty pharmacies, clinics, infusion centers and alternative sites of care while preserving operational continuity and regulatory compliance.

Buyers
Morris & Dickson
Targets
Prodigy Health
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.